Captor Therapeutics Spolka Akcyjna

CTX

PLCPTRT00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:48 2024-04-18 am EDT			5-day change	1st Jan Change
82.4 ^PLN	+0.73%		+3.00%	-16.77%

2023	Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Captor Therapeutics Spolka Akcyjna has filed an IPO.

March 22, 2021 at 12:00 am EDT

Captor Therapeutics Spolka Akcyjna has filed an IPO.

Security Name: Shares
Security Type: Common Stock

Latest news about Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 28	CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-07	CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-06	CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
Ono Pharmaceutical and Captor Therapeutics Announces Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases	22-11-14	CI
Captor Therapeutics S.A. Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma	22-08-10	CI
Captor Therapeutics S.A. Announces Molecular Targets of CT-01 Program Developing TPD Therapy for Hepatocellular Carcinoma	22-04-12	CI
Certain Ordinary Bearer Shares of Captor Therapeutics Spolka Akcyjna are subject to a Lock-Up Agreement Ending on 12-APR-2022.	22-04-11	CI
Captor Therapeutics S.A. Presents Compelling in Vivo Proof-Of-Concept Data from CT-01 Program in Hepatocellular Carcinoma	22-01-13	CI
Certain Ordinary Bearer Shares of Captor Therapeutics Spolka Akcyjna are subject to a Lock-Up Agreement Ending on 14-OCT-2021.	21-10-13	CI
Captor Therapeutics Spolka Akcyjna has completed an IPO in the amount of PLN 183.954 million.	21-04-08	CI
Captor Therapeutics Spolka Akcyjna has filed an IPO.	21-03-22	CI

Chart Captor Therapeutics Spolka Akcyjna

Duration

Period

Chart Captor Therapeutics Spolka Akcyjna

More charts

Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.

Sector

Biotechnology & Medical Research

Calendar

2024-05-26 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Captor Therapeutics Spolka Akcyjna

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

82.4 PLN

Average target price

115 PLN

Spread / Average Target

+39.56%

Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CAPTOR THERAPEUTICS SPOLKA AKCYJNA	-16.77%	94.25M
IQVIA HOLDINGS INC.	-1.82%	41.35B
LONZA GROUP AG	+44.25%	40.38B
MODERNA, INC.	+2.56%	39.05B
CELLTRION, INC.	-12.11%	26.67B
ICON PUBLIC LIMITED COMPANY	+3.09%	24.07B
ALNYLAM PHARMACEUTICALS, INC.	-24.16%	18.36B
MEDPACE HOLDINGS, INC.	+22.12%	11.6B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.74%	11.68B
UNITED THERAPEUTICS CORPORATION	+7.75%	11.15B

Other Biotechnology & Medical Research